JOANNA EDWARDS: Open Payments
NPI 1063947067 · OBLONG, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 30 payments from 12 companies in 2025. Trend: 2023 $514 · 2024 $664 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $89 |
| ABBVIE INC. | 4 | $75 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Lilly USA, LLC | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 3 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Lundbeck LLC | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Alkermes, Inc. | 1 | $21 |
Products named: REXULTI, VRAYLAR, CAPLYTA, Auvelity, FANAPT, LEQVIO, SPRAVATO, MOUNJARO.
Industry payments across IL — which companies pay providers there.
